These images are provided for non-commercial use under a Creative Commons License (BY-NC-ND). To license a high resolution version, please contact our image library who will discuss fees, terms and waivers.
Download this imageCreative commons explained - what it means, how you can use our's and other people's content.
Bloody Cranesbill (Geranium Sanguineum)
Draughtsman: Schouman, Aert
A plant with erect branched stem with racimes of reddish-brown flowers, leaves sessile and deeply lobed in landscape with river and fort-like house.
Height: 392 mm
Width: 263 mm
Method of acquisition: Bequeathed (1973) by Fairhaven, Henry Rogers Broughton
Support composed of laid paper
Watercolour : Watercolour on laid paper
Accession number: PD.127-1973.50
Primary reference Number: 32312
Stable URI
Owner or interested party:
The Fitzwilliam Museum
Associated department:
Paintings, Drawings and Prints
This record can be cited in the Harvard Bibliographic style using the text below:
The Fitzwilliam Museum (2024) "Bloody Cranesbill (Geranium Sanguineum)" Web page available at: https://data.fitzmuseum.cam.ac.uk/id/object/32312 Accessed: 2024-12-25 13:29:16
To cite this record on Wikipedia you can use this code snippet:
{{cite web|url=https://data.fitzmuseum.cam.ac.uk/id/object/32312
|title=Bloody Cranesbill (Geranium Sanguineum)
|author=The Fitzwilliam Museum|accessdate=2024-12-25 13:29:16|publisher=The
University of Cambridge}}
To call these data via our API (remember this needs to be authenticated) you can use this code snippet:
https://data.fitzmuseum.cam.ac.uk/api/v1/objects/object-32312
To use this as a simple code embed, copy this string:
<div class="text-center">
<figure class="figure">
<img src="https://data.fitzmuseum.cam.ac.uk/imagestore/pdp/pdp34/PD_127_1973_50.jpg"
alt="Bloody Cranesbill (Geranium Sanguineum)"
class="img-fluid" />
<figcaption class="figure-caption text-info">Bloody Cranesbill (Geranium Sanguineum)</figcaption>
</figure>
</div>
Updates about future exhibitions and displays, family activities, virtual events & news. You'll be the first to know...
